These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

977 related articles for article (PubMed ID: 15513337)

  • 1. Effect of treatment with the Molecular Adsorbents Recirculating System on arterial amino acid levels and cerebral amino acid metabolism in patients with hepatic encephalopathy.
    Schmidt LE; Tofteng F; Strauss GI; Larsen FS
    Scand J Gastroenterol; 2004 Oct; 39(10):974-80. PubMed ID: 15513337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albumin dialysis has a favorable effect on amino acid profile in hepatic encephalopathy.
    Koivusalo AM; Teikari T; Höckerstedt K; Isoniemi H
    Metab Brain Dis; 2008 Dec; 23(4):387-98. PubMed ID: 18773287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral blood flow velocity increases during a single treatment with the molecular adsorbents recirculating system in patients with acute on chronic liver failure.
    Schmidt LE; Svendsen LB; Sørensen VR; Hansen BA; Larsen FS
    Liver Transpl; 2001 Aug; 7(8):709-12. PubMed ID: 11510016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acid dysbalance in liver failure is favourably influenced by recirculating albumin dialysis (MARS).
    Loock J; Mitzner SR; Peters E; Schmidt R; Stange J
    Liver; 2002; 22 Suppl 2():35-9. PubMed ID: 12220301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracorporal liver support with molecular adsorbents recirculating system in patients with hepatitis B-associated fulminant hepatic failure.
    Tsai MH; Chen YC; Wu CS; Ho YP; Fang JT; Lien JM; Yang C; Chu YY; Liu NJ; Lin CH; Chiu CT; Chen PC
    Int J Clin Pract; 2005 Nov; 59(11):1289-94. PubMed ID: 16236082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in plasma amino acids during extracorporeal liver support by fractionated plasma separation and adsorption.
    Rifai K; Das A; Rosenau J; Ernst T; Kretschmer U; Haller H; Fliser D; Manns MP
    Artif Organs; 2010 Feb; 34(2):166-70. PubMed ID: 19817727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of fractionated plasma separation and adsorption on cerebral amino acid metabolism and oxidative metabolism during acute liver failure.
    Bjerring PN; Hauerberg J; Frederiksen HJ; Nielsen HB; Clemmesen JO; Larsen FS
    J Hepatol; 2012 Oct; 57(4):774-9. PubMed ID: 22691571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catholic university experience with molecular adsorbent recycling system in patients with severe liver failure.
    Di Campli C; Santoro MC; Gaspari R; Merra G; Zileri Dal Verme L; Zocco MA; Piscaglia AC; Di Gioacchino G; Novi M; Santoliquido A; Flore R; Tondi P; Proietti R; Gasbarrini G; Pola P; Gasbarrini A
    Transplant Proc; 2005; 37(6):2547-50. PubMed ID: 16182739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral hemodynamic and metabolic profiles in fulminant hepatic failure: relationship to outcome.
    Aggarwal S; Obrist W; Yonas H; Kramer D; Kang Y; Scott V; Planinsic R
    Liver Transpl; 2005 Nov; 11(11):1353-60. PubMed ID: 16237715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric acute liver failure with molecular adsorbent recirculating system treatment.
    Novelli G; Rossi M; Morabito V; Pugliese F; Ruberto F; Perrella SM; Novelli S; Spoletini G; Ferretti G; Mennini G; Berloco PB
    Transplant Proc; 2008; 40(6):1921-4. PubMed ID: 18675090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The treatment of molecular adsorbents recirculating system artificial liver in severe liver failure patients with multiple organ dysfunction syndrome].
    Guo LM; Liu JY; Xu DZ; Li BS; Han H; Wang LH; Zhang WY; Lu LH; Guo X; Sun FX; Zhang HY; Liu XD; Zhang JP; Yao J; He ZP; Wang MM
    Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):455-7. PubMed ID: 12939172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of normalization of plasma amino acids on hepatic encephalopathy in man.
    Fischer JE; Rosen HM; Ebeid AM; James JH; Keane JM; Soeters PB
    Surgery; 1976 Jul; 80(1):77-91. PubMed ID: 818729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of extracorporeal blood purification methods: Molecular Adsorbent Recirculating System (MARS) for hepatic and renal function replacement].
    Marangoni R
    G Ital Nefrol; 2007; 24 Suppl 38():92-6. PubMed ID: 17922457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation minimization is safe and effective in albumin liver dialysis using the molecular adsorbent recirculating system.
    Tan HK; Yang WS; Chow P; Lui HF; Choong HL; Wong KS
    Artif Organs; 2007 Mar; 31(3):193-9. PubMed ID: 17343694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preconditioning by extracorporeal liver support (MARS) of patients with cirrhosis and severe liver failure evaluated for living donor liver transplantation -- a pilot study.
    Choi JY; Bae SH; Yoon SK; Cho SH; Yang JM; Han JY; Ahn BM; Chung KW; Sun HS; Kim DG
    Liver Int; 2005 Aug; 25(4):740-5. PubMed ID: 15998424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver transplantation avoided in patients with fulminant hepatic failure who received albumin dialysis with the molecular adsorbent recirculating system while on the waiting list: impact of the duration of therapy.
    Camus C; Lavoué S; Gacouin A; Compagnon P; Boudjéma K; Jacquelinet C; Thomas R; Le Tulzo Y
    Ther Apher Dial; 2009 Dec; 13(6):549-55. PubMed ID: 19954480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mars and Prometheus: our clinical experience in acute chronic liver failure.
    Faenza S; Baraldi O; Bernardi M; Bolondi L; Coli L; Cucchetti A; Donati G; Gozzetti F; Lauro A; Mancini E; Pinna AD; Piscaglia F; Rasciti L; Ravaioli M; Ruggeri G; Santoro A; Stefoni S
    Transplant Proc; 2008 May; 40(4):1169-71. PubMed ID: 18555140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure.
    Mitzner SR; Stange J; Klammt S; Peszynski P; Schmidt R; Nöldge-Schomburg G
    J Am Soc Nephrol; 2001 Feb; 12 Suppl 17():S75-82. PubMed ID: 11251037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of molecular adsorbent recirculating system in acute liver failure attributable to dengue hemorrhagic fever.
    Penafiel A; Devanand A; Tan HK; Eng P
    J Intensive Care Med; 2006; 21(6):369-71. PubMed ID: 17095501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One hundred sixteen cases of acute liver failure treated with MARS.
    Novelli G; Rossi M; Pretagostini M; Pugliese F; Ruberto F; Novelli L; Nudo F; Bussotti A; Corradini S; Martelli S; Berloco PB
    Transplant Proc; 2005; 37(6):2557-9. PubMed ID: 16182742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.